Account
Inquiry
XCE Tirzepatide is a novel peptide compound acting as a dual agonist for both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This synthetic peptide demonstrates potent activity in metabolic regulation research applications.
The peptide sequence features optimized amino acid modifications for enhanced stability and receptor binding affinity. XCE Tirzepatide shows particular promise in studies related to glucose homeostasis and weight management mechanisms.
Our production facility maintains strict GMP-compliant standards for all peptide synthesis processes. Each batch undergoes comprehensive quality control testing including HPLC purity verification, mass spectrometry confirmation, and endotoxin testing.
Available packaging options include lyophilized powder in various concentrations from research-scale vials to bulk quantities for institutional use. All materials are shipped with complete analytical documentation including Certificate of Analysis.
Important Note: This product is intended for research purposes only. Not for human or veterinary use.
